Status
Conditions
Treatments
About
To evaluate the safety and effectiveness of a fixed-dose combination containing valsartan and rosuvastatin (Rovatitan® Tablet) in patient with hypertension and hypercholesterolemia
Full description
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
1,000 participants in 1 patient group
Loading...
Central trial contact
songyi Park
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal